Capturing Endothelial Cells by Coronary Stents - From Histology to Clinical Outcomes

1. Buccheri D, Piraino D, Andolina G, et al. Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment. J Thorac Dis 2016; 8(10): E1150-62.10.21037/jtd.2016.10.93Search in Google Scholar

2. Borhani S, Hassanajili S, Tafti SHA, Rabbani S. Cardiovascular stents: overview, evolution, and next generation. Prog Biomater 2018; 7: 175-205.10.1007/s40204-018-0097-ySearch in Google Scholar

3. Lowe HC, Oesterle SN, Khachigian LM. Coronary instent restenosis: Current status and future strategies. JACC 2002; 39(2): 183-93.10.1016/S0735-1097(01)01742-9Search in Google Scholar

4. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. NEJM 2003; 349(14): 1315-23.10.1056/NEJMoa035071Search in Google Scholar

5. Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. NEJM 2004; 350(3): 221-31.10.1056/NEJMoa032441Search in Google Scholar

6. Joner M, Nakazawa G, Finn AV, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. JACC 2008; 52(5): 333-42.10.1016/j.jacc.2008.04.030Search in Google Scholar

7. van Beusekom HM, Sorop O, van den Heuvel M, et al. Endothelial function rather than endothelial restoration is altered in paclitaxel-as compared to bare metal-, sirolimus and tacrolimus-eluting stents. EuroIntervention 2010; 6(1): 117-25.10.4244/EIJV6I1A18Search in Google Scholar

8. Farb A, Boam AB. Stent thrombosis redux – the FDA perspective. NEJM 2007; 356(10): 984-7.10.1056/NEJMp068304Search in Google Scholar

9. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007; 369: 667-78.10.1016/S0140-6736(07)60314-6Search in Google Scholar

10. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27(7): 1500-10.10.1161/ATVBAHA.107.14422017510464Search in Google Scholar

11. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004; 109: 701-5.10.1161/01.CIR.0000116202.41966.D4Search in Google Scholar

12. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011; 57(11): 1314-22.10.1016/j.jacc.2011.01.011309331021376502Search in Google Scholar

13. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.10.1126/science.275.5302.9649020076Search in Google Scholar

14. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85(3): 221-8.10.1161/01.RES.85.3.221Search in Google Scholar

15. Plouffe BD, Kniazeva T, Mayer JE Jr, et al. Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine. FASEB J 2009; 23(10): 3309-14.10.1096/fj.09-130260274767719487310Search in Google Scholar

16. Rakocevic J, Orlic D, Mitrovic-Ajtic O, et al. Endothelial cell markers from clinician’s perspective. Exp Mol Pathol 2017; 102(2); 303-13.10.1016/j.yexmp.2017.02.00528192087Search in Google Scholar

17. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, et al. Expression of the CD34 gene in vascular endothelial cells. Blood 1990; 75(12): 2417-26.10.1182/blood.V75.12.2417.2417Search in Google Scholar

18. Tumbar T, Guasch G, Greco V, et al. Defining the epithelial stem cell niche in skin. Science. 2004; 303: 359-63.10.1126/science.1092436240592014671312Search in Google Scholar

19. Brown J, Greaves MF, Molgaard HV. The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol 1991; 3:175-84.10.1093/intimm/3.2.1751709048Search in Google Scholar

20. Heider KH, Aziz S, Al-Reshidi MA. Endothelial progenitor cells for cellular angiogenesis and repair: lessons learned from experimental animal models. Regen Med 2017; 12(8): 969-82.10.2217/rme-2017-007429215316Search in Google Scholar

21. Chopra H, Hunk MK, Kwong Dl, et al. Insights into endothelial progenitor cells: origin, classification, potentials, and prospects. Stem Cells Int 2018; 18:2018: 9847015.10.1155/2018/9847015627649030581475Search in Google Scholar

22. Kutryk MJ, Kuliszewski MA. In vivo endothelial progenitor cell seeding for the accelerated endothelialization of endovascular devices. Am J Cardiol 2003; 92 (6A): 94L-5L.Search in Google Scholar

23. van Beusekom HM, Ertas G, Sorop O, et al. The genous endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries. Catheter Cardiovasc Interv 2012; 79(2): 231-42.10.1002/ccd.2292821834062Search in Google Scholar

24. Larsen K, Cheng C, Tempel D, et al. Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model. Eur Heart J 2012; 33(1): 120-8.10.1093/eurheartj/ehr196324921821733913Search in Google Scholar

25. Nakazawa G, Granada JF, Alviar CL, et al. Anti-CD34 antibodies immobilized on the surface of sirolimuseluting stents enhance stent endothelialization. JACC Cardiovasc Interv 2010; 3(1): 68-75.10.1016/j.jcin.2009.09.01520129572Search in Google Scholar

26. Granada JF, Inami S, Aboodi MS, et al. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv 2010; 3: 257–66.10.1161/CIRCINTERVENTIONS.109.91993620442358Search in Google Scholar

27. Tan A, Goh D, Farhatnia Y, et al. An Anti-CD34 Antibody-Functionalized Clinical-Grade POSS-PCU Nanocomposite Polymer for Cardiovascular Stent Coating Applications: A Preliminary Assessment of Endothelial Progenitor Cell Capture and Hemocompatibility. PLoS One 2013; 8(10).10.1371/journal.pone.0077112379300924116210Search in Google Scholar

28. Aoki J, Serruys PW, van Beusekom H, et al. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry. J Am Coll Cardiol 2005; 45(10): 1574-9.10.1016/j.jacc.2005.01.04815893169Search in Google Scholar

29. Duckers HJ, Soullie T, den Heijer P, et al. Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent) EuroIntervention 2007; 3: 350-8.Search in Google Scholar

30. den Dekker WK, Houtgraaf JH, Onuma Y, et al. Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (GenousStent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Atherosclerosis 2011; 219: 245-52.10.1016/j.atherosclerosis.2011.06.03221763653Search in Google Scholar

31. Silber S, Damman P, Klomp M, et al. Clinical results after coronary stenting with the Genous bio-engineered R stent: 12month outcomes of the eHEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. EuroIntervention 2011; 6(7): 819-25.10.4244/EIJV6I7A14121252015Search in Google Scholar

32. Wohrle J, Birkemeyer R, Markovic S, et al. Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart 2011; 97: 1338-42.10.1136/hrt.2011.22656321617163Search in Google Scholar

33. Co M, Tay E, Lee CH, et al. Use of endothelial progenitor cell capture stent (Genous bio-engineered R stent) during primary percutaneous coronary intervention in acute myocardial infarction: intermediate-to long-term clinical follow-up. Am Heart J 2008; 155(1): 128-132.10.1016/j.ahj.2007.08.03118082503Search in Google Scholar

34. Choi WG, Kim SH, Yoon HS, et al. Impact of an endothelial progenitor cell capturing stent on coronary microvascular function: comparison with drug-eluting stents. Korean J Intern Med 2015; 30(1): 42-8.10.3904/kjim.2015.30.1.42429356225589834Search in Google Scholar

35. Beijk MA, Klomp M, Verouden NJ, et al. Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study. Eut Heart J 2010; 31(9): 1055-64.10.1093/eurheartj/ehp476286217819933225Search in Google Scholar

36. Beijk MA, Klomp M, van Geloven N, et al. Two-year follow-up of the Genous endothelial progenitor cell capturing stent versus the taxus liberte stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheter Cardiovasc Interv 2011; 78(2): 189-95.10.1002/ccd.2314321542109Search in Google Scholar

37. Chong E, Poh KK, Liang S, et al. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction. J Interv Cardiol 2010; 23(2): 101-8.10.1111/j.1540-8183.2010.00534.x20236214Search in Google Scholar

38. Lee YP, Tay E, Lee CH, et al.Endothelial progenitor cell capture stent implantation in patients with ST segment elevation acute myocardial infarction: one year follow-up. EuroIntervention 2010; 5(6): 698-702.10.4244/EIJV5I6A11520142221Search in Google Scholar

39. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002; 105(25): 3017-24.10.1161/01.CIR.0000018166.84319.55Search in Google Scholar

40. Duckers HJ, Silber S, de Winter R, et al. Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the Healing II trial: evaluation of an endothelial progenitor cell capturing stent. EuroIntervention 2007; 3(1): 67-75.10.4244/EIJV3I3A64Search in Google Scholar

41. Garg S, Duckers HJ, Serruys PW. Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice? Eur Heart J 2012; 31: 1032-1035.10.1093/eurheartj/ehp591Search in Google Scholar

42. Granada JF, Inami S, Aboodi MS, et al. Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv 2010; 3(3): 257-66.10.1161/CIRCINTERVENTIONS.109.91993620442358Search in Google Scholar

43. Haude M, Lee SW, Worthley SG, et al. The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent. JACC Cardiovasc Interv 2013; 6: 334-43.10.1016/j.jcin.2012.10.01823523459Search in Google Scholar

44. Woudstra P, Kalkman DN, den Heijer P, et al. 1-year results of the REMEDEE registry: Clinical outcomes after deployment of the abluminal sirolimus-coated bioengineered (combo) stent in a multicenter, prospective all-comers registry. JACC Cardiovasc Interv 2016; 9: 1127-34.10.1016/j.jcin.2016.02.05227209254Search in Google Scholar

45. Kalkman DN, Woudstra P, Lu H, et al. Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome. Catheter Cardiovasc Interv 2017; 90: E31-7.10.1002/ccd.2691528145609Search in Google Scholar

46. Kalkman DN, Woudstra P, den Heijer P, et al. One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent. Int J Cardiol 2017; 226: 60-4.10.1016/j.ijcard.2016.10.03227788391Search in Google Scholar

47. Saito S, Krucoff MW, Nakamura S, et al. Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich’s Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome. Eur Heart J 2018; 29(26): 2460-8.10.1093/eurheartj/ehy275603708729931092Search in Google Scholar

48. Jakobsen L, Christiansen EH, Maeng M, et al. Randomized clinical comparison of the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent with the sirolimus-eluting Orsiro stent in patients treated with percutaneous coronary intervention: Rationale and study design of the Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) X trial. Am Heart J 2018; 202: 49-53.10.1016/j.ahj.2018.04.01929807307Search in Google Scholar

49. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.10.1016/j.jacc.2006.03.04216814667Search in Google Scholar

50. van Beusekom HM, Saia F, Zindler JD, et al. Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur Heart J 2007; 28: 974-9.10.1093/eurheartj/ehm06417434882Search in Google Scholar

51. Brancati MF, Burzotta F, Trani C, et al. Coronary stents and vascular response to implantation: literature review. Pragm Obs Res 2017; 8: 137-48.10.2147/POR.S132439551687628761388Search in Google Scholar

52. Juni RP, Duckers HJ, Vanhoutte PM, et al. Oxidative stress and pathological changes after coronary interventions. J Am Coll Cardiol 2013; 61(14): 1471-81.10.1016/j.jacc.2012.11.06823500310Search in Google Scholar